Bigfork Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $2.2M
Latest Deal Amount
  • Investors
  • 9

Bigfork General Information

Description

Developer of DNA-based antibacterial drugs designed to counter the clinical challenge of the rise of drug-resistant bacterial strains. The company's drugs offer the next generation of antibiotics to tackle the rising threat of superbugs, enabling doctors to provide to the rapid development of drug candidates against challenging infections for which there are few therapeutic options.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Bankside 300 Peachman Way
  • Broadland Business Park, Norfolk
  • Norwich NR7 0LB
  • England, United Kingdom

Bigfork Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bigfork Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 17-Sep-2019 $2.2M 00.000 Completed Generating Revenue
6. Later Stage VC 24-Apr-2018 00.000 00.000 00.00 Completed Generating Revenue
5. Later Stage VC 01-Dec-2016 00000 00.000 00000 Completed Generating Revenue
4. Grant 15-Jan-2013 00000 00.000 Completed Generating Revenue
3. Early Stage VC 05-Apr-2012 00000 00.000 00.000 Completed Startup
2. Early Stage VC 06-Oct-2010 $1.96M $2.65M 00.000 Completed Startup
1. Seed Round 01-Jan-2008 $690K $690K 00.000 Completed Startup
To view Bigfork’s complete valuation and funding history, request access »

Bigfork Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 000,000 00.000000 00.0 00.0 00 00.0 0.000
Ordinary 2,883 $0.014112 $12.23 $12.23 1x $12.23 0.06%
Ordinary 27,574 $0.014112 $16.3 $16.3 1x $16.3 0.58%
To view Bigfork’s complete cap table history, request access »

Bigfork Executive Team (3)

Name Title Board Seat Contact Info
Michael McArthur Ph.D Co-Founder & Chief Scientific Officer
You’re viewing 1 of 3 executive team members. Get the full list »

Bigfork Board Members (6)

Name Representing Role Since
Oliver Sexton Bigfork Board Member 000 0000
You’re viewing 1 of 6 board members. Get the full list »

Bigfork Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bigfork Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Global AMR Innovation Fund Government 000 0000 000000 0
Development Bank of Wales Venture Capital Minority 000 0000 000000 0
Meltwind Venture Capital Minority 000 0000 000000 0
Novo Holdings Venture Capital Minority 000 0000 000000 0
Wren Capital Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »